Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma
Clinical trial NCT04168944 · UNKNOWN
Trial details
- NCT number
- NCT04168944
- Sponsor
- RenJi Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2022-09-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.